Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Escherichia coli ST131-H22 as a Foodborne Uropathogen.

Liu CM, Stegger M, Aziz M, Johnson TJ, Waits K, Nordstrom L, Gauld L, Weaver B, Rolland D, Statham S, Horwinski J, Sariya S, Davis GS, Sokurenko E, Keim P, Johnson JR, Price LB.

MBio. 2018 Aug 28;9(4). pii: e00470-18. doi: 10.1128/mBio.00470-18.

2.

Rapid and Extensive Expansion in the U.S. of a New Multidrug-Resistant Escherichia coli Clonal Group, Sequence Type ST1193.

Tchesnokova VL, Rechkina E, Larson L, Ferrier K, Weaver JL, Schroeder DW, She R, Butler-Wu SM, Aguero-Rosenfeld ME, Zerr D, Fang FC, Ralston J, Riddell K, Scholes D, Weissman S, Parker K, Spellberg B, Johnson JR, Sokurenko EV.

Clin Infect Dis. 2018 Jun 29. doi: 10.1093/cid/ciy525. [Epub ahead of print]

PMID:
29961843
3.

The Uropathogenic Escherichia coli Subclone ST131-H30 Is Responsible for Most Antibiotic Prescription Errors at an Urgent Care Clinic.

Tchesnokova V, Riddell K, Scholes D, Johnson JR, Sokurenko EV.

Clin Infect Dis. 2018 Jun 29. doi: 10.1093/cid/ciy523. [Epub ahead of print]

PMID:
29961840
4.

CHTyper, a Web Tool for Subtyping of Extraintestinal Pathogenic Escherichia coli Based on the fumC and fimH Alleles.

Roer L, Johannesen TB, Hansen F, Stegger M, Tchesnokova V, Sokurenko E, Garibay N, Allesøe R, Thomsen MCF, Lund O, Hasman H, Hammerum AM.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e00063-18. doi: 10.1128/JCM.00063-18. Print 2018 Apr. No abstract available.

PMID:
29436420
5.

Epidemiology and Antimicrobial Resistance Characteristics of the Sequence Type 131-H30 Subclone Among Extraintestinal Escherichia coli Collected From US Children.

Miles-Jay A, Weissman SJ, Adler AL, Tchesnokova V, Sokurenko EV, Baseman JG, Zerr DM.

Clin Infect Dis. 2018 Jan 18;66(3):411-419. doi: 10.1093/cid/cix805.

PMID:
29020219
6.

Development of a Web Tool for Escherichia coli Subtyping Based on fimH Alleles.

Roer L, Tchesnokova V, Allesøe R, Muradova M, Chattopadhyay S, Ahrenfeldt J, Thomsen MCF, Lund O, Hansen F, Hammerum AM, Sokurenko E, Hasman H.

J Clin Microbiol. 2017 Aug;55(8):2538-2543. doi: 10.1128/JCM.00737-17. Epub 2017 Jun 7.

7.

Inactivation of Transcriptional Regulators during Within-Household Evolution of Escherichia coli.

Kisiela DI, Radey M, Paul S, Porter S, Polukhina K, Tchesnokova V, Shevchenko S, Chan D, Aziz M, Johnson TJ, Price LB, Johnson JR, Sokurenko EV.

J Bacteriol. 2017 Jun 13;199(13). pii: e00036-17. doi: 10.1128/JB.00036-17. Print 2017 Jul 1.

8.

Bacterial clonal diagnostics as a tool for evidence-based empiric antibiotic selection.

Tchesnokova V, Avagyan H, Rechkina E, Chan D, Muradova M, Haile HG, Radey M, Weissman S, Riddell K, Scholes D, Johnson JR, Sokurenko EV.

PLoS One. 2017 Mar 28;12(3):e0174132. doi: 10.1371/journal.pone.0174132. eCollection 2017.

9.

Clonal distribution and associated characteristics of Escherichia coli clinical and surveillance isolates from a military medical center.

Manges AR, Mende K, Murray CK, Johnston BD, Sokurenko EV, Tchesnokova V, Johnson JR.

Diagn Microbiol Infect Dis. 2017 Apr;87(4):382-385. doi: 10.1016/j.diagmicrobio.2017.01.007. Epub 2017 Jan 20.

PMID:
28139277
10.

Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center.

Johnson JR, Johnston B, Thuras P, Launer B, Sokurenko EV, Miller LG.

mSphere. 2016 Nov 23;1(6). pii: e00314-16. eCollection 2016 Nov-Dec.

11.

SpyB, a Small Heme-Binding Protein, Affects the Composition of the Cell Wall in Streptococcus pyogenes.

Edgar RJ, Chen J, Kant S, Rechkina E, Rush JS, Forsberg LS, Jaehrig B, Azadi P, Tchesnokova V, Sokurenko EV, Zhu H, Korotkov KV, Pancholi V, Korotkova N.

Front Cell Infect Microbiol. 2016 Oct 13;6:126. eCollection 2016.

12.

Household Clustering of Escherichia coli Sequence Type 131 Clinical and Fecal Isolates According to Whole Genome Sequence Analysis.

Johnson JR, Davis G, Clabots C, Johnston BD, Porter S, DebRoy C, Pomputius W, Ender PT, Cooperstock M, Slater BS, Banerjee R, Miller S, Kisiela D, Sokurenko EV, Aziz M, Price LB.

Open Forum Infect Dis. 2016 Jun 16;3(3):ofw129. eCollection 2016 Sep.

13.
14.

Separate F-Type Plasmids Have Shaped the Evolution of the H30 Subclone of Escherichia coli Sequence Type 131.

Johnson TJ, Danzeisen JL, Youmans B, Case K, Llop K, Munoz-Aguayo J, Flores-Figueroa C, Aziz M, Stoesser N, Sokurenko E, Price LB, Johnson JR.

mSphere. 2016 Jun 29;1(4). pii: e00121-16. doi: 10.1128/mSphere.00121-16. eCollection 2016 Jul-Aug.

15.

Uropathogenic Escherichia coli Metabolite-Dependent Quiescence and Persistence May Explain Antibiotic Tolerance during Urinary Tract Infection.

Leatham-Jensen MP, Mokszycki ME, Rowley DC, Deering R, Camberg JL, Sokurenko EV, Tchesnokova VL, Frimodt-Møller J, Krogfelt KA, Leth Nielsen K, Frimodt-Møller N, Sun G, Cohen PS.

mSphere. 2016 Jan 20;1(1). pii: e00055-15. doi: 10.1128/mSphere.00055-15. eCollection 2016 Jan-Feb.

16.

Pathoadaptive Mutations in Uropathogenic Escherichia coli.

Sokurenko E.

Microbiol Spectr. 2016 Apr;4(2). doi: 10.1128/microbiolspec.UTI-0020-2015. Review.

PMID:
27227300
17.

Complete Genome Sequence of a CTX-M-15-Producing Escherichia coli Strain from the H30Rx Subclone of Sequence Type 131 from a Patient with Recurrent Urinary Tract Infections, Closely Related to a Lethal Urosepsis Isolate from the Patient's Sister.

Johnson TJ, Aziz M, Liu CM, Sokurenko E, Kisiela DI, Paul S, Andersen P, Johnson JR, Price LB.

Genome Announc. 2016 May 12;4(3). pii: e00334-16. doi: 10.1128/genomeA.00334-16.

18.

The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.

Johnson JR, Thuras P, Johnston BD, Weissman SJ, Limaye AP, Riddell K, Scholes D, Tchesnokova V, Sokurenko E.

Clin Infect Dis. 2016 Jun 15;62(12):1529-1536. doi: 10.1093/cid/ciw193. Epub 2016 Mar 29.

19.

Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131.

Stoesser N, Sheppard AE, Pankhurst L, De Maio N, Moore CE, Sebra R, Turner P, Anson LW, Kasarskis A, Batty EM, Kos V, Wilson DJ, Phetsouvanh R, Wyllie D, Sokurenko E, Manges AR, Johnson TJ, Price LB, Peto TE, Johnson JR, Didelot X, Walker AS, Crook DW; Modernizing Medical Microbiology Informatics Group (MMMIG).

MBio. 2016 Mar 22;7(2):e02162. doi: 10.1128/mBio.02162-15.

20.

A Novel 7-Single Nucleotide Polymorphism-Based Clonotyping Test Allows Rapid Prediction of Antimicrobial Susceptibility of Extraintestinal Escherichia coli Directly From Urine Specimens.

Tchesnokova V, Avagyan H, Billig M, Chattopadhyay S, Aprikian P, Chan D, Pseunova J, Rechkina E, Riddell K, Scholes D, Fang FC, Johnson JR, Sokurenko EV.

Open Forum Infect Dis. 2016 Jan 18;3(1):ofw002. doi: 10.1093/ofid/ofw002. eCollection 2016 Jan.

21.

Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli.

Liu Y, Mémet S, Saban R, Kong X, Aprikian P, Sokurenko E, Sun TT, Wu XR.

Sci Rep. 2015 Nov 9;5:16234. doi: 10.1038/srep16234.

22.

PanCoreGen - Profiling, detecting, annotating protein-coding genes in microbial genomes.

Paul S, Bhardwaj A, Bag SK, Sokurenko EV, Chattopadhyay S.

Genomics. 2015 Dec;106(6):367-72. doi: 10.1016/j.ygeno.2015.10.001. Epub 2015 Oct 9.

23.

Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.

Johnson JR, Porter SB, Thuras P, Johnson TJ, Price LB, Tchesnokova V, Sokurenko EV.

Antimicrob Agents Chemother. 2015 Nov;59(11):7132-5. doi: 10.1128/AAC.01687-15. Epub 2015 Aug 31.

24.

Rapid Identification of Rectal Multidrug-resistant Escherichia coli Before Transrectal Prostate Biopsy.

Tchesnokova VL, Ottley LL, Sakamoto K, Fierer J, Sokurenko E, Liss MA.

Urology. 2015 Dec;86(6):1200-5. doi: 10.1016/j.urology.2015.07.008. Epub 2015 Aug 20.

25.

Erratum for Johnson et al., intensity and mechanisms of fluoroquinolone resistance within the H30 and H30Rx subclones of Escherichia coli sequence type 131 compared with other fluoroquinolone-resistant E. coli.

Johnson JR, Johnston B, Kuskowski MA, Sokurenko EV, Tchesnokova V.

Antimicrob Agents Chemother. 2015 Sep;59(9):5871. doi: 10.1128/AAC.01716-15. No abstract available.

26.

Inactive conformation enhances binding function in physiological conditions.

Yakovenko O, Tchesnokova V, Sokurenko EV, Thomas WE.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9884-9. doi: 10.1073/pnas.1503160112. Epub 2015 Jul 27.

27.

Synonymous and nonsynonymous distances help untangle convergent evolution and recombination.

Chi PB, Chattopadhyay S, Lemey P, Sokurenko EV, Minin VN.

Stat Appl Genet Mol Biol. 2015 Aug;14(4):375-89. doi: 10.1515/sagmb-2014-0078.

28.

Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.

Johnson JR, Johnston B, Kuskowski MA, Sokurenko EV, Tchesnokova V.

Antimicrob Agents Chemother. 2015 Aug;59(8):4471-80. doi: 10.1128/AAC.00673-15. Epub 2015 May 18. Erratum in: Antimicrob Agents Chemother. 2015 Sep;59(9):5871.

29.

Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli.

Kisiela DI, Avagyan H, Friend D, Jalan A, Gupta S, Interlandi G, Liu Y, Tchesnokova V, Rodriguez VB, Sumida JP, Strong RK, Wu XR, Thomas WE, Sokurenko EV.

PLoS Pathog. 2015 May 14;11(5):e1004857. doi: 10.1371/journal.ppat.1004857. eCollection 2015 May.

30.

Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients - an unrecognized CF pathogen?

Barillova P, Tchesnokova V, Dübbers A, Küster P, Peters G, Dobrindt U, Sokurenko EV, Kahl BC.

Int J Med Microbiol. 2014 May;304(3-4):415-21. doi: 10.1016/j.ijmm.2014.02.008. Epub 2014 Feb 19.

PMID:
24630795
31.

Escherichia coli isolate for studying colonization of the mouse intestine and its application to two-component signaling knockouts.

Lasaro M, Liu Z, Bishar R, Kelly K, Chattopadhyay S, Paul S, Sokurenko E, Zhu J, Goulian M.

J Bacteriol. 2014 May;196(9):1723-32. doi: 10.1128/JB.01296-13. Epub 2014 Feb 21.

32.

Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.

Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, Junka AF, Maczynska B, Denamur E.

J Clin Microbiol. 2014 May;52(5):1358-65. doi: 10.1128/JCM.03502-13. Epub 2014 Feb 5.

33.

The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.

Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV.

MBio. 2013 Dec 17;4(6):e00377-13. doi: 10.1128/mBio.00377-13.

34.

Complete Genome Sequence of the Epidemic and Highly Virulent CTX-M-15-Producing H30-Rx Subclone of Escherichia coli ST131.

Andersen PS, Stegger M, Aziz M, Contente-Cuomo T, Gibbons HS, Keim P, Sokurenko EV, Johnson JR, Price LB.

Genome Announc. 2013 Dec 5;1(6). pii: e00988-13. doi: 10.1128/genomeA.00988-13.

35.

Response to Giufre et al.

Johnson JR, Price LB, Sokurenko EV.

J Infect Dis. 2014 Feb 15;209(4):630-1. doi: 10.1093/infdis/jit582. Epub 2013 Nov 7. No abstract available.

36.

Conformational inactivation induces immunogenicity of the receptor-binding pocket of a bacterial adhesin.

Kisiela DI, Rodriguez VB, Tchesnokova V, Avagyan H, Aprikian P, Liu Y, Wu XR, Thomas WE, Sokurenko EV.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19089-94. doi: 10.1073/pnas.1314395110. Epub 2013 Nov 4.

37.

Structural and population characterization of MrkD, the adhesive subunit of type 3 fimbriae.

Stahlhut SG, Chattopadhyay S, Kisiela DI, Hvidtfeldt K, Clegg S, Struve C, Sokurenko EV, Krogfelt KA.

J Bacteriol. 2013 Dec;195(24):5602-13. doi: 10.1128/JB.00753-13. Epub 2013 Oct 11.

38.

Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010.

Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, Tchesnokova V, Price LB, Johnson JR.

Antimicrob Agents Chemother. 2013 Dec;57(12):6385-8. doi: 10.1128/AAC.01604-13. Epub 2013 Sep 30.

39.

The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.

Banerjee R, Johnston B, Lohse C, Chattopadhyay S, Tchesnokova V, Sokurenko EV, Johnson JR.

Antimicrob Agents Chemother. 2013 Dec;57(12):5912-7. doi: 10.1128/AAC.01065-13. Epub 2013 Sep 16.

40.

Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.

Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR; VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators.

Clin Infect Dis. 2013 Nov;57(9):1256-65. doi: 10.1093/cid/cit503. Epub 2013 Aug 6.

41.

Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome.

Tchesnokova V, Billig M, Chattopadhyay S, Linardopoulou E, Aprikian P, Roberts PL, Skrivankova V, Johnston B, Gileva A, Igusheva I, Toland A, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson BT, Fang FC, Kahl B, Price LB, Weissman SJ, Limaye A, Scholes D, Johnson JR, Sokurenko EV.

J Clin Microbiol. 2013 Sep;51(9):2991-9. doi: 10.1128/JCM.00984-13. Epub 2013 Jul 10.

42.

Allosteric coupling in the bacterial adhesive protein FimH.

Rodriguez VB, Kidd BA, Interlandi G, Tchesnokova V, Sokurenko EV, Thomas WE.

J Biol Chem. 2013 Aug 16;288(33):24128-39. doi: 10.1074/jbc.M113.461376. Epub 2013 Jul 2.

43.

rbrothers: R Package for Bayesian Multiple Change-Point Recombination Detection.

Irvahn J, Chattopadhyay S, Sokurenko EV, Minin VN.

Evol Bioinform Online. 2013 Jun 12;9:235-8. doi: 10.4137/EBO.S11945. Print 2013.

44.

Accelerated gene evolution through replication-transcription conflicts.

Paul S, Million-Weaver S, Chattopadhyay S, Sokurenko E, Merrikh H.

Nature. 2013 Mar 28;495(7442):512-5. doi: 10.1038/nature11989.

45.

Microbial variome database: point mutations, adaptive or not, in bacterial core genomes.

Chattopadhyay S, Taub F, Paul S, Weissman SJ, Sokurenko EV.

Mol Biol Evol. 2013 Jun;30(6):1465-70. doi: 10.1093/molbev/mst048. Epub 2013 Mar 14.

46.

Tracking recent adaptive evolution in microbial species using TimeZone.

Chattopadhyay S, Paul S, Dykhuizen DE, Sokurenko EV.

Nat Protoc. 2013 Apr;8(4):652-65. doi: 10.1038/nprot.2013.031. Epub 2013 Mar 7.

PMID:
23471110
47.

Evolutionary analysis points to divergent physiological roles of type 1 fimbriae in Salmonella and Escherichia coli.

Kisiela DI, Chattopadhyay S, Tchesnokova V, Paul S, Weissman SJ, Medenica I, Clegg S, Sokurenko EV.

MBio. 2013 Mar 5;4(2). pii: e00625-12. doi: 10.1128/mBio.00625-12.

48.

Tight conformational coupling between the domains of the enterotoxigenic Escherichia coli fimbrial adhesin CfaE regulates binding state transition.

Liu Y, Esser L, Interlandi G, Kisiela DI, Tchesnokova V, Thomas WE, Sokurenko E, Xia D, Savarino SJ.

J Biol Chem. 2013 Apr 5;288(14):9993-10001. doi: 10.1074/jbc.M112.413534. Epub 2013 Feb 7.

49.

Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response.

Dreux N, Denizot J, Martinez-Medina M, Mellmann A, Billig M, Kisiela D, Chattopadhyay S, Sokurenko E, Neut C, Gower-Rousseau C, Colombel JF, Bonnet R, Darfeuille-Michaud A, Barnich N.

PLoS Pathog. 2013 Jan;9(1):e1003141. doi: 10.1371/journal.ppat.1003141. Epub 2013 Jan 24.

50.

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.

Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV.

J Infect Dis. 2013 Mar 15;207(6):919-28. doi: 10.1093/infdis/jis933. Epub 2013 Jan 3.

Supplemental Content

Loading ...
Support Center